Application
Western blot analysis of extracts from COLO cells, using MEGF9 Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | MEGF9 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to MEGF9 |
| Immunogen | The antiserum was produced against synthesized peptide derived from human MEGF9. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAWB |
| ELISA: 1:40000Optimal dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | Multiple EGF-like domain protein 5 Multiple epidermal growth factor-like domains 9 EGFlike domaincontaining protein 5 Multiple epidermal growth factorlike domains 9 EGF-like domain-containing protein 5 MEGF9 Multiple epidermal growth factorlike domai |
|---|---|
| Target | MEGF9 |
| Molecular Weight(MW) | 62 kDa (note) |
| Tissue Specificity | MEGF9 Antibody detects endogenous levels of total MEGF9 protein. |
Application
Western blot analysis of extracts from COLO cells, using MEGF9 Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | ELISA: 1:40000Optimal dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
